Skip to main content
SpringerLink
Log in

Auf der Suche nach Einflussfaktoren auf die Wahl des Geschäftsmodells – Das Beispiel der Biotech-Industrie

  • Chapter
  • First Online:
Innovative Geschäftsmodelle

Zusammenfassaug

Während das Konzept des Geschäftsmodells in den letzten zehn Jahren zunehmend mehr Beachtung seitens der Forschung und der Wirtschaft erhalten hat, fokussieren sich die meisten Beiträge in diesem Feld doch nur auf Möglichkeiten der Geschäftsmodell-Konfiguration und potenzielle Beziehungen zur Performance. Ein Forschungsstrang, der dagegen bisher weniger Beachtung fand, ist die Identifizierung von Faktoren, die die Wahl des Geschäftsmodells beeinflussen. Der folgende Beitrag wirft Licht auf diese Fragestellung und verwendet als Anschauungsbeispiel aktuelle Geschäftsmodelle aus der Biotech-Industrie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  • Amit, R./Zott, C. (2001). Value creation in e-business. In: Strategic Management Journal, 22(6–7), S. 493–520.

    Article  Google Scholar 

  • Barney, J. (1991). Firm resources and sustained competitive advantage. In: Journal of Management, 17(1), S. 199–120.

    Google Scholar 

  • Bode-Greuel, K.M./Greuel, J.M. (2005). Determining the value of drug development candidates and technology platforms. In: Journal of Commercial Biotechnology, 11(2), S. 155–170.

    Article  Google Scholar 

  • Bower, D.J. (2003). Business model fashion and the academic spinout firm. In: R&D Management, 33(2), S. 97–106.

    Article  Google Scholar 

  • Carlin, W./Soskice, D. (1997). Shocks to the system: the German political economy under stress. In: National Institute Economic Review, 159(1), S. 57–76.

    Article  Google Scholar 

  • Casper, S. (2000). Institutional adaptiveness, technology policy, and the diffusion of new business models: The case of German biotechnology. In: Organization Studies, 21, S. 887–914.

    Article  Google Scholar 

  • Casper, S./Kettler, H. (2001). National institutional frameworks and the hybridiziation of entrepreneurial business models: The German and UK biotechnology sectors. In: Industry and Innovation, 8(1), S. 5–30.

    Article  Google Scholar 

  • Champenois, C./Engel, D./Heneric, O. (2006). What kind of German biotechnology start-ups do venture capital companies and corporate investors prefer for equity investments? In: Applied Economics, 38(5), S. 505–518.

    Article  Google Scholar 

  • Chesbrough, H. (2010). Business model innovation: Opportunities and barriers. In: Long Range Planning, 43(2–3), S. 354–363.

    Article  Google Scholar 

  • Dohse, D. (2000). Technology policy and the regions – the case of the BioRegio contest. In: Research Policy, 29(9), S. 1111–1133.

    Article  Google Scholar 

  • Ehrlich, S./De Noble, A./Moore, T./Weaver, R. (1994). After the cash arrives: a comparative study of venture capital and private investor involvement in entrepreneurial firms. In: Journal of Business Venturing, 9(1), S. 67–82.

    Article  Google Scholar 

  • Ernst & Young (2010). Beyond borders – Global biotechnology report 2010. Cambridge: Ernst & Young.

    Google Scholar 

  • Fisken, J./Rutherford, J. (2002). Business models and investment trends in the biotechnology industry in europe. In: Journal of Commercial Biotechnology, 8(3), S. 191–199.

    Google Scholar 

  • Freeman, C. (1995). The ’National System of Innovation’ in historical perspective. In: Cambridge Journal of Economics, 19, S. 5–24.

    Google Scholar 

  • Friedmann, Y. (2010). Time for a new business model. In: Journal of Commercial Biotechnology, 16, S. 1–2.

    Article  Google Scholar 

  • Gambardella, A./McGahan, A.M. (2010). Business-model innovation: General purpose technologies and their implications for industry structure. In: Long Range Planning, 43(2–3), S. 262–271.

    Article  Google Scholar 

  • Hambrick, D.C./Mason, P.A. (1984). Upper echelons: The organization as a reflection of its top managers. In: Academy of Management Review, 9(2), S. 193–206.

    Article  Google Scholar 

  • Kind, S./zu Knyphausen-Aufseß, D. (2007). What is ’business development’? The case of biotechnology. In: Schmalenbach Business Review, 59, S. 176–199.

    Google Scholar 

  • zu Knyphausen-Aufseß, D./Meinhardt, Y. (2002). Revisiting Strategy: Ein Ansatz zur Systematisierung von Geschäftsmodellen. In Bieger, T/Bickhoff, N./Caspers, R./zu Knyphausen-Aufseß, D./Reding, K (Hrsg.): Zukünftige Geschäftsmodelle. Konzept und Anwendung in der Netzökonomie (S. 63–85). Berlin et al.: Springer-Verlag,.

    Google Scholar 

  • Konde, V. (2008). Biotechnology business models: An Indian perspective. In: Journal of Commercial Biotechnology, 15(3), S. 215–226.

    Article  Google Scholar 

  • Kor, Y.Y. (2003). Experience-based top management team competence and sustained growth. In: Organization Science, 14(6), S. 707–719.

    Article  Google Scholar 

  • Lanza, G. (2009). Building today’s platform company. http://www.nature.com/bioent/2009/090601/full/bioe.2009.6.html

  • Magretta, J. (2002). Why business models matter. In: Harvard Business Review, S. 1–8.

    Google Scholar 

  • Momma, S./Sharp, M. (1999I). Developments in new biotechnology firms in Germany. In: Technovation, 19(5), S. 267–282.

    Article  Google Scholar 

  • Nelson, R. (Hrsg.) (2003). National Innovation Systems. A Comparative Analysis. New York/Oxford: Oxford University Press.

    Google Scholar 

  • Nelson, T. (2003). The persistence of founder influence: management, ownership, and performance effects at initial public offering. In: Strategic Management Journal, 24(8), S. 707–724.

    Article  Google Scholar 

  • Osterwalder, A./Pigneur, Y. (2004). An ontology for e-business models. In: Currie, W. (Hrsg.): Value Creation from E-Business Models (S. 65–97). Oxford: Elsevier Butterworth-Heinemann.

    Chapter  Google Scholar 

  • Patzelt, H./zu Knyphausen-Aufseß, D./Nikol, P. (2008). Top management teams, business models, and performance of biotechnology ventures: An upper echelon perspective. In: British Journal of Management, 15, S. 205–221.

    Article  Google Scholar 

  • Rajala, R./Rossi, M./Tuunainen, V. (2003). A framework for analyzing software business models. In Proceedings of the Eleventh European Conference on Information Systems. Neapel, Italien, S. 1614–1627.

    Google Scholar 

  • Reed, R./DeFilippi, R. (1990). Causal ambiguity, barriers to imitation, and sustainable competitive advantage. In: Academy of Management Review, 15(1), S. 88–102.

    Article  Google Scholar 

  • Rothman, H./Kraft, A. (2006). Downstream and into deep biology: Evolving business models in ‘top tier genomics companies. In: Journal of Commercial Biotechnology, 12(2), S. 86–97.

    Article  Google Scholar 

  • Scarlett, J.A. (1999). Biotechnology’s emerging opportunities: Lessons from the Bauhaus. In: Nature Biotechnology, 17, S. BE13-BE15.

    Google Scholar 

  • Wieland, T. (2004). Innovationskultur: theoretische und empirische Annäherungen an einen Begriff. Available at: http://www.lrz.de/~thomas_wieland/papers/wieland_2.pdf [Zugegriffen am 18. September 2010].

  • Zott, C./Amit, R. (2007). Business model design and the performance of entrepreneurial firms. In: Organization Science, 18, S. 181–199.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Technischen Universität Berlin, Berlin, Deutschland

    Martin Heitmann, Dodo zu Knyphausen-Aufseß & Robert Mansel

  2. Hochschule für Wirtschaft und Recht Berlin, Berlin, Deutschland

    Andreas Zaby

Authors
  1. Martin Heitmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dodo zu Knyphausen-Aufseß
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Mansel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andreas Zaby
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Heitmann .

Editor information

Editors and Affiliations

  1. , IMP-HSG, Universität St Gallen, Dufourstrasse 40a, St. Gallen, 9000, Switzerland

    Thomas Bieger

  2. , Strategische Führung und, Technische Universität Berlin, Straße des 17. Juni 135/H92, Berlin, 10623, Germany

    Dodo zu Knyphausen-Aufseß

  3. Consultants Holding GmbH, .bits Knowledge Group, Roland Berger Strategy, Karl-Arnold-Platz 1, Düsseldorf, 40474, Germany

    Christian Krys

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Heitmann, M., Knyphausen-Aufseß, D., Mansel, R., Zaby, A. (2011). Auf der Suche nach Einflussfaktoren auf die Wahl des Geschäftsmodells – Das Beispiel der Biotech-Industrie. In: Bieger, T., zu Knyphausen-Aufseß, D., Krys, C. (eds) Innovative Geschäftsmodelle. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18068-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18068-2_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-18067-5

  • Online ISBN: 978-3-642-18068-2

  • eBook Packages: Business and Economics (German Language)

Publish with us

Policies and ethics

Search

Navigation